FDA
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)
-
-
-
-
-
-
-
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
-
-
-
-
-
-
-
Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
Mereo BioPharma (MREO) Reports on Recent Program Developments and Provides Financial Update
-
-
-
-
-
-
-
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Mereo BioPharma (MREO) Regains Nasdaq Compliance
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

